Feb 21 (Reuters) - A shortage of Danish drugmaker Novo
Nordisk's popular weight-loss and diabetes drugs,
Wegovy and Ozempic, has been resolved, the U.S. Food and Drug
Administration's website showed on Friday.
(Reporting by Bhanvi Satija in Bengaluru;Editing by Arun
Koyyur)